Pharmacogenetics of antidepressant response

A. Serretti, A. Drago, Michael N. Liebman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Nowadays, the efficacy of antidepressant treatment and the profile of side effects are not predictable: sociodemographic and clinical variables have not provided clinicians with consistent support. Emerging evidence reports promising results from the genetic approach: pharmacogenetics identifies which genetic variations are associated with drug treatment outcome. Both pharmacodynamic and pharmacokinetic key genes have been investigated, and even though consistent conclusions are yet to come, several lines of evidence have led researchers to assume a promising future of effective pharmacogenetic-based pretreatment assessment. The most important antidepressant pharmacogenetic results in this field are reviewed in this chapter and future research lines are proposed.

Original languageEnglish
Title of host publicationBiomarkers for Psychiatric Disorders
PublisherSpringer US
Pages315-353
Number of pages39
ISBN (Print)9780387792507
DOIs
Publication statusPublished - 2009

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pharmacogenetics of antidepressant response'. Together they form a unique fingerprint.

  • Cite this

    Serretti, A., Drago, A., & Liebman, M. N. (2009). Pharmacogenetics of antidepressant response. In Biomarkers for Psychiatric Disorders (pp. 315-353). Springer US. https://doi.org/10.1007/978-0-387-79251-4_14